1 ANNEX, Regulation (EU) 2015/408

In forcesince 7 Oct 2020

1-methylcyclopropene

8-hydroxyquinoline

aclonifen

amitrole

bifenthrin

bromadiolone

bromuconazole

carbendazim

carbetamide

chlorotoluron (unstated stereochemistry)

copper compounds (variants copper hydroxide, copper oxychloride, copper oxide, Bordeaux mixture and tribasic copper sulphate)

cyproconazole

cyprodinil

diclofop

difenacoum

difenoconazole

diflufenican

dimethoate

dimoxystrobin

diquat

emamectin

epoxiconazole

esfenvalerate

ethoprophos

etofenprox

etoxazole

famoxadone

fenamiphos

fenbutatin oxide

fipronil

fludioxonil

flufenacet

flumioxazine

fluometuron

fluopicolide

fluquinconazole

flurochloridone

gamma-cyhalothrin

glufosinate

halosulfuron-methyl

haloxyfop-P

imazamox

imazosulfuron

ipconazole

isoproturon

isopyrazam

lambda-cyhalothrin

lenacil

linuron

lufenuron

mecoprop

metalaxyl

metam

metconazole

methomyl

metribuzin

metsulfuron-methyl

molinate

myclobutanil

nicosulfuron

oxadiargyl

oxadiazon

oxamyl

oxyfluorfen

paclobutrazol

pendimethalin

pirimicarb

prochloraz

profoxydim

propiconazole

propoxycarbazone

prosulfuron

quinoxyfen

quizalofop-P (variant quizalofop-P-tefuryl)

sulcotrione

tebuconazole

tebufenpyrad

tembotrione

tepraloxydim

thiacloprid

tri-allate

triasulfuron

triazoxide

warfarin

ziram

Changed on 7 Oct 2020

carbetamide

emamectin

flurochloridone gamma-cyhalothrin

halosulfuron-methyl

ipconazole

tembotrione

  1. 7 Oct 2020 – todayin force
  2. 4 Dec 2017 – 7 Oct 2020earlier wording
  3. 11 Mar 2015 – 4 Dec 2017earlier wording